How many capsules are in a decaris package
* required field
* required field
Suggested Products
Space for your product
Klaudia Ćwiąkała Pharmacist, Editor
3 months ago
In 2026, the European Medicines Agency (EMA) recommended the withdrawal of all marketing authorisations for medicines containing levamisole (m.in. Decaris) throughout the European Union.
The decision was related to the confirmation of the risk of serious side effects, including leukoencephalopathy. This substance is currently not authorised for use in humans in the EU.
More information: https://www.gdziepolek.pl/substancje/lewamizol
Angelika Talar-Śpionek Pharmacist, Editor
3 years ago
According to the data contained in the Register of Medicinal Products, Decaris is currently not authorized for marketing in Poland.